Should mRNA be Restricted to Research Clinical Trials? Maria Zeee and Dr. McCullough

Synthetic mRNA used for vaccines or medicinal purposes should be restricted to clinical trials where there is voluntary participation, informed consent, proper data safety and monitoring, and risk mitigation. As more states work to pull mRNA from public use, we are returning to where medical science should be on the genetic platform—limited to research studies where proper testing and refinement should be done before attempting FDA licensure and US market entry. Dr. McCullough on Vigilant News with Maria Zeee Feb 16, 2025.